Denka Revamps Mission 2030 Plan to Rebuild Earnings and Enter New Growth Phase

Denka Co ( (JP:4061) ) just unveiled an announcement.

Denka has updated its Mission 2030 management plan with a Phase 2 program covering fiscal years 2026 to 2028, following an expected recovery to ¥25 billion in operating income and at least 5% ROE in fiscal 2025. The revised plan targets rebuilding earning power, aiming for record operating income and an 8% ROE by strengthening ICT and energy and healthcare businesses, reshaping sustainable living into cash-generative operations, resolving the DPE issue while limiting financial damage, and tightly selecting investments to restore its balance sheet.

Management also plans to expand existing businesses through 2030 under a so-called Trickle Out Strategy while planting seeds for at least 10 new initiatives for the period beyond 2030. By pursuing a growth model that balances differently paced ICT, energy, and healthcare segments, Denka aims to secure sustainable, distinctive growth and reinforce its role in providing solutions to social issues, signaling to stakeholders a shift into a new growth stage under a stronger execution-focused regime.

The most recent analyst rating on (JP:4061) stock is a Hold with a Yen3565.00 price target. To see the full list of analyst forecasts on Denka Co stock, see the JP:4061 Stock Forecast page.

More about Denka Co

Denka Co., Ltd. is a Japanese chemical manufacturer active in ICT and energy materials, healthcare-related products, and sustainable living businesses. The company is positioning itself around high-value-added growth fields while managing legacy operations, with an emphasis on profitability, return on equity, and financial stability as it executes its long-term Mission 2030 plan.

Average Trading Volume: 773,683

Technical Sentiment Signal: Buy

Current Market Cap: Yen287.1B

For detailed information about 4061 stock, go to TipRanks’ Stock Analysis page.